PCN127 - Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting
| Autor: | Ferrusi, I.L., Kulin, N.A., Goeree, R., Leighl, N., Pullenayegum, E.M., Phillips, K., Marshall, D. |
|---|---|
| Zdroj: | In Value in Health May 2014 17(3):A90-A90 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect